LENS: Landscape of Effective Neoantigens Software
Authors:
- Wolfgang BeckabirWBWolfgang Beckabir
- Misha FiniMFMisha Fini
- Othmane JadiOJOthmane Jadi
- Alex RubinsteynARAlex Rubinsteyn
- Benjamin G. VincentBVBenjamin G. Vincent
Preprint
Abstract
Motivation: Elimination of cancer cells by T cells is a critical mechanism of anti-tumor immunity and cancer immunotherapy response. T cells recognize cancer cells by engagement of T cell receptors with peptide epitopes presented by major histocompatibility complex (MHC) molecules on the cancer cell surface. Peptide epitopes can be derived from antigen proteins coded for by multiple genomic sources. Bioinformatics tools used to identify tumor-specific epitopes via analysis of DNA and RNA sequencing data have largely focused on epitopes derived from somatic variants, though a smaller number have evaluated potential antigens from other genomic sources. Results: We report here an open-source workflow utilizing the Nextflow DSL2 workflow manager, Landscape of Effective Neoantigen Software (LENS), which predicts tumor-specific and tumor-associated antigens from single nucleotide variants, insertions and deletions, fusion events, splice variants, cancer testis antigens, overexpressed self-antigens, viruses, and endogenous retroviruses. The primary advantage of LENS is that it expands the breadth of genomic sources of discoverable tumor antigens using genomics data. Other advantages include modularity, extensibility, ease of use, and harmonization of relative expression level and immunogenicity prediction across multiple genomic sources. We present an analysis of 115 acute myeloid leukemia (AML) samples to demonstrate the utility of LENS. We expect LENS will be a valuable platform and resource for T cell epitope discovery bioinformatics, especially in cancers with few somatic variants where tumor-specific epitopes from alternative genomic sources are an elevated priority. Availability: More information about LENS, including workflow documentation and instructions, can be found at https://gitlab.com/landscape-of-effective-neoantigens-software Contact: steven_vensko@med.unc.edu , benjamin_vincent@med.unc.edu Supplementary information: Supplementary data are available at Bioinformatics online.Keywords
All Related Versions
- Published version: Bioinformatics, 39 (6).
This publication has 50 references indexed in Scilit:
- Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell ImmunogenicityThe Journal of Immunology, 2016
- gEVE: a genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomesDatabase: The Journal of Biological Databases and Curation, 2016
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cellsScience, 2015
- Overexpressed oncogenic tumor-self antigensHuman Vaccines & Immunotherapeutics, 2014
- Sequenza: allele-specific copy number and mutation profiles from tumor sequencing dataAnnals of Oncology, 2014
- Kaposi's sarcoma and its associated herpesvirusNature Reviews Cancer, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational ResearchClinical Cancer Research, 2009
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigensNucleic Acids Research, 2008
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006